ENANTIOS

Enantios develops measurement technology to help pharmaceutical researchers understand the molecular structures of complex chiral molecules and biologics. Based on technology developed at ETH Zürich, its approach measures Raman optical activity (ROA), a technique studied for its potential in pharmaceutical analysis. By providing structural insights, Enantios aims to support drug discovery and characterization while addressing limitations of conventional tools that can slow research and increase manufacturing costs.

The company offers ROA instruments designed to make measurement more accessible, with Enantios handling the laser work so users can focus on their samples. It also provides measurement services, including proof-of-concept studies and individual molecule measurements. Its stated capabilities include working without chiral HPLC, crystallization, or purified reference standards, and a compact design intended to fit in a glove box. Enantios also shares technical resources and white papers covering applications such as absolute structure determination, isomeric and enantiomeric excess measurement, biologics analysis, and antibody-drug conjugate characterization.